ALPHA
0303
0.270

ALPHA

0303
ALPHA IVF GROUP BERHAD KLSE Summary
Ace Market : Health Care Providers

0.270

-0.005 (-1.8%)
High 0.275
Low 0.270
Open 0.000
Volume 1,241,100
Volume (B/S) 1,244,100 / 650,800
Price Bid/Ask 0.270 / 0.275
   
52w 0.260 - 0.345
ROE 28.50
P/E 23.75
EPS 1.14
DPS 1.00
DY 3.70%
 
NTA 0.0400
P/B 6.75
RPS 3.91
PSR 6.91
Market Cap 1,312.2M
Shares (mil) 4,860.00
RQoQ RYoY
CAGR
3Y -53.5% TTM 16.8%
5Y 17.1% TTM -39.7%
RSI(14) Neutral 35.7
Stochastic(14) Neutral 50.0
Stochastic RSI(14) Oversold 0.0
Average Volume (3M) 1,598,200
Relative Volume 0.0
Login for more stats

EPS DPS NTA Revenue P/L Quarter Q Date Financial Year Announced ROE QoQ% YoY% Report
31 May, 2026
0.2500 0.000 0.0400 47.3m 12.0m 2 2025-11-30 31 May, 2026 2026-01-22 6.3% 21.5% 20.5%
0.3100 0.500 0.0400 52.1m 15.3m 1 2025-08-31 31 May, 2026 2025-10-28 7.8% 4.9% 6.3%
31 May, 2025
0.3300 0.000 0.0400 50.0m 16.1m 4 2025-05-31 31 May, 2025 2025-07-28 8.3% 35% 14.7%
0.2400 0.500 0.0400 40.6m 11.9m 3 2025-02-28 31 May, 2025 2025-04-22 6.0% 21.2% 12.4%
0.3100 0.000 0.0400 43.2m 15.1m 2 2024-11-30 31 May, 2025 2025-01-21 7.8% 5% 23.6%
0.3000 0.450 0.0400 43.0m 14.4m 1 2024-08-31 31 May, 2025 2024-10-21 7.5% 2.7% 0%
31 May, 2024
0.2900 0.000 0.0400 46.7m 14.0m 4 2024-05-31 31 May, 2024 2024-07-17 7.3% 3.1% 0%
0.3000 0.490 0.0100 40.7m 13.6m 3 2024-02-29 31 May, 2024 2024-04-16 30.0% 11.2% 0%
0.2700 0.210 0.0200 38.5m 12.2m 2 2023-11-30 31 May, 2024 2024-03-18 13.5% 0% 0%

Financial Year Revenue ('000) Net ('000) EPS DP% Net % Report
31 May, 2026 99,394 27,278 0.5600 0.89
31 May, 2025 176,842 57,454 1.1800 0.81 44.3% View
31 May, 2024 125,990 39,811 0.8600 0.81 View

Announced Financial Year Subject EX Date Payment Date Amount Indicator
31 May, 2026
22 Jan 2026 31 May 2026 Interim Dividend 18 Mar 2026 31 Mar 2026 0.0050 Currency View
31 May, 2025
28 Jul 2025 31 May 2025 Interim Dividend 08 Aug 2025 29 Aug 2025 0.0050 Currency View
03 Dec 2024 31 May 2025 Interim Dividend 17 Dec 2024 31 Dec 2024 0.0050 Currency View
31 May, 2024
17 Jul 2024 31 May 2024 Interim Dividend 30 Jul 2024 15 Aug 2024 0.0045 Currency View

Announced EX Date Subject Ratio Offer
No records

Name Price Change Volume Gearing Premium Premium % Maturity
No warrants found.

Announced Date Change Type Shares Name
27 Jan 2026 26 Jan 2026 Acquired 2,733,400 DATO DR LEE SOON SOO
31 Oct 2025 30 Oct 2025 Acquired 420,000 ACE SPECIALISTS SDN BHD
31 Oct 2025 29 Oct 2025 Acquired 2,358,000 DATO' DR LEE SOON SOO
31 Oct 2025 30 Oct 2025 Acquired 420,000 DATO' DR LEE SOON SOO
31 Oct 2025 29 Oct 2025 Acquired 2,358,000 ACE SPECIALISTS SDN BHD
09 Jun 2025 28 May 2025 Acquired 534,400 ACE SPECIALISTS SDN BHD
09 Jun 2025 28 May 2025 Acquired 534,400 DATO DR LEE SOON SOO
14 Mar 2025 12 Mar 2025 Acquired 1,855,400 DATO' DR LEE SOON SOO


Recent News
  • Alpha IVF says worst of start-up pains is over, still eyes regional expansion
    FERTILITY care specialist Alpha IVF Group Bhd (KL:ALPHA) is doubling down on regional expansion and expects earnings to return to the growth path later this year as start-up-related costs ease and its newly launched in-vitro fertilisation (IVF) centres begin to contribute to profit. Aft...
    TheEdge
  • 3利好发酵 中小型股购兴回温
    (吉隆坡3日讯)在国内经济基本面稳健、外国直接投资(FDI)持续流入及投资者积极寻求超额回酬的推动下,分析员看好估值具吸引力的中小型股在2026年有望受惠于多项独特催化剂及资金轮动,迎来更亮眼表现。受惠多项独特催化剂及资金轮动兴业研究分析员指出,上周四(29日)举行的第六场兴业小型股企业线上接洽活动(SCCA)反应热烈,吸引约70名来自亚洲各地的基金经理和分析员参与,显示市场对中小型股的兴趣正在回温。“本次活动汇集一批相对低调、希望加强与投资者互动的公司,同时也包括我们看好的部分中小型股,...
    Sinchew
  • 诸多利好烘托业务展望 估值诱人小型股可突围
    兴业投行研究指出,在宏观环境趋稳、美元走软及市场资金轮动背景下,估值具吸引力的小型股,有望在2026年迎来表现窗口。...
    Nanyang
  • Positive outlook for Alpha IVF’s growth
    PETALING JAYA: Despite the anticipated near-term softness in its financial year ending May 31, 2026 (FY26), arising from pre-operating startup costs for its four new in vitro fertilisation (IVF) centres, analysts remain optimistic about Alpha IVF Group Bhd's outlook for FY27.
    TheStar
  • 今日选股|阿儿法国际支出增 3年财测遭下调
    券商 :达证券投资建议 :买进目标价 :37仙闭市价 :29仙(截至1月23日)每股收益 :1.2仙(2026财年估计)本益比 :25.1倍(2026财年估计)股息收益率:3.2%(2026财年估计)我们下调阿儿法国际(ALPHA,0303,创业板医疗保健)的销售预测4%,考虑到行政支出预期更高,因此将2026至2028财年的盈利预测调整至5710万令吉、7220万令吉及8400万令吉,低于此前预测的6950万令吉、8320万令吉及9450万令吉。同时,我们在维持2027年本益比...
    Chinapress




Comments
Login to comment.

Tan Hao Yu
Like · Reply
The Indonesian market had been a strategic play by ALPHA IVF – in financial year 2025 oocyte pick-ups (OPUs) from Indonesia accounted for 71.4% of fertility centre Genesis IVF’s total OPUs
Bowman Su
Like · Reply
According to MBSB, Malaysia’s healthcare sector could become a key growth driver this year, especially in high-end medical tourism and local biopharma production
Andrew Ho
Alpha IVF will ride on the VM 2026 wave too
Like · 14 hours · translate